Compare
Albemarle Corp vs Avient Corp vs Eastman Chemical Co vs Trinseo PLC
| Latest fiscal year | Albemarle Corp ALB | Avient Corp AVNT | Eastman Chemical Co EMN | Trinseo PLC TSEOQ |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $5.14B | $3.26B | $8.75B | $2.97B |
| Revenue growth (YoY) | -4.4% | +0.6% | -6.7% | -15.3% |
| Gross margin | 13.0% | 31.2% | 21.1% | 5.6% |
| Operating margin | -7.1% | 6.2% | n/a | -8.5% |
| Net margin | -9.9% | 2.5% | 5.4% | -18.3% |
| Net income | -$510.63M | $81.90M | $474.00M | -$545.60M |
| EPS (Diluted) | -$5.76 | $0.89 | $4.10 | -$15.24 |
| Operating cash flow | $1.28B | $301.60M | $970.00M | -$102.40M |
| Free cash flow | $692.47M | $195.00M | $424.00M | -$153.40M |
| Cash & equivalents | n/a | n/a | $566.00M | $146.70M |
| Total assets | $16.37B | $6.03B | $14.86B | $2.28B |
| Total liabilities | n/a | n/a | $8.82B | n/a |
| Shareholders' equity | $9.78B | $2.37B | $5.96B | -$1.10B |
| Return on year-end equity | -5.2% | 3.4% | 8.0% | n/a |
| Shares outstanding | 117.72M | n/a | 223.94M | 36.00M |
Revenue, most recent five fiscal years
| Fiscal year | Albemarle Corp | Avient Corp | Eastman Chemical Co | Trinseo PLC |
|---|---|---|---|---|
| Latest | $5.14B Ended 2025-12-31 | $3.26B Ended 2025-12-31 | $8.75B Ended 2025-12-31 | $2.97B Ended 2025-12-31 |
| 1 year earlier | $5.38B Ended 2024-12-31 | $3.24B Ended 2024-12-31 | $9.38B Ended 2024-12-31 | $3.51B Ended 2024-12-31 |
| 2 years earlier | $9.62B Ended 2023-12-31 | $3.14B Ended 2023-12-31 | $9.21B Ended 2023-12-31 | $3.68B Ended 2023-12-31 |
| 3 years earlier | $7.32B Ended 2022-12-31 | $3.40B Ended 2022-12-31 | $10.58B Ended 2022-12-31 | $4.97B Ended 2022-12-31 |
| 4 years earlier | $3.33B Ended 2021-12-31 | $3.32B Ended 2021-12-31 | $10.48B Ended 2021-12-31 | $4.83B Ended 2021-12-31 |